BCYC Q4 2018 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+61.4% YoY

Gross Profit

-$5M-514.3% margin

Operating Income

-$8M-713.5% margin

Net Income

-$7M-628.3% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-34.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$207,000

Balance Sheet

Total Assets

$82M

Total Liabilities

$151M

Stockholders' Equity

-$70M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$655,000	+61.4%
Gross Profit	-$5M	-$3M	-57.6%
Operating Income	-$8M	-$6M	-25.3%
Net Income	-$7M	-$6M	-14.0%